Consumer Health

 

 

 

 
 

In 2003 we:
• Gained market segment share across all business units
• Achieved strong performance, driven by Sandoz and OTC
• Successfully launched new products in all business units, especially in the US

 

 
• Achieved substantial sales growth of +24% versus previous year in USD (+16% in LC), reaching USD 8.8 billion
• Increased operating income by +40% versus previous year in USD
 
 
 
 

Shaping Consumer Health

The Consumer Health Division focuses on creating, developing, manufacturing and marketing a wide range of competitively differentiated products that restore, maintain or improve the health and well being of our consumers. The Division, which includes our Sandoz generics, OTC self-medication, Animal Health, Medical Nutrition (including our Nutrition & Sant้ franchise), Infant & Baby, and CIBA Vision business units, places considerable emphasis on the development of strong, consumer oriented and trustworthy brands. Each business unit has a leading market position in growth oriented healthcare segments beyond our core pharmaceuticals business, providing essential, high quality health-related products.
In the dynamic world of consumer healthcare, aging populations are increasingly affluent and knowledgeable about their health, and the benefits of self-medication. The success of each business unit depends upon its ability to anticipate and meet the needs of consumers and health professionals worldwide.
Our mission at Novartis Consumer Health is to give a voice to the consumer in everything we do, in order to deliver accelerated sales growth and leadership positions.

 

 

 

 
 

 

 
32